Assessment of initial vancomycin dosing in neonates

about

Achievement of Vancomycin Therapeutic Goals in Critically Ill Patients: Early Individualization May Be Beneficial.Levofloxacin Use in the Neonate: A Case Series.

P2860

Q36747464-B48DD596-C59D-42DA-A157-173BDE741E57 Q41455427-E56AB2BE-2E46-4F1C-B2FD-063C96883D8E

P2860

Assessment of initial vancomycin dosing in neonates

Item

http://www.wikidata.org/entity/Q39110114

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Assessment of initial vancomycin dosing in neonates

@en

Assessment of initial vancomycin dosing in neonates.

@nl

type

Item

label

Assessment of initial vancomycin dosing in neonates

@en

Assessment of initial vancomycin dosing in neonates.

@nl

prefLabel

Assessment of initial vancomycin dosing in neonates

@en

Assessment of initial vancomycin dosing in neonates.

@nl

P1476

Assessment of initial vancomycin dosing in neonates

@en

P2093

Albert Akierman

http://www.w3.org/2001/XMLSchema#string

Belal Alshaikh

http://www.w3.org/2001/XMLSchema#string

Deonne Dersch-Mills

http://www.w3.org/2001/XMLSchema#string

Kamran Yusuf

http://www.w3.org/2001/XMLSchema#string

Tanner Bengry

http://www.w3.org/2001/XMLSchema#string

P2860

Antibacterial-induced nephrotoxicity in the newborn.

Risk factors and prevention of late-onset sepsis in premature infants.

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

An evaluation of initial vancomycin dosing in infants, children, and adolescents.

Vancomycin: pharmacokinetics and administration regimens in neonates.

The pharmacokinetic and pharmacodynamic properties of vancomycin.

Coagulase-negative staphylococcal infections in the neonate and child: an update.

Improved vancomycin dosing in children using area under the curve exposure.

Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.

P304

e30-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/PCH/19.6.E30

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25332665

http://www.w3.org/2001/XMLSchema#string

P932

4173964

http://www.w3.org/2001/XMLSchema#string

Assessment of initial vancomycin dosing in neonates

about

P2860

P2860

Assessment of initial vancomycin dosing in neonates

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932